Hariharan Venkatesan

This inventor holds 42 USPTO granted patents and 11 published patent applications, plus 7 CIPO patents and 17 EPO patents, primarily in Prolyl Hydroxylase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Emory University. Active years: 2000-2024.

USPTO Granted Patents = 42 (Patent Applications = 11)

% Patents Active = 61.9

CIPO Patents = 7 (Patent Applications = 7)

EPO Patents = 17 (Patent Applications = 18)

Average Co-Inventor Count = 7.5

ph-index = 7

Forward Citations = 197(Granted Patents)

Location History:

Atlanta, GA (US) (2000 - 2003)
San Diego, CA (US) (2004 - 2024)

Company Filing History:

36 out of 2,100

Janssen Pharmaceutica Nv

Years Active: 2000-2024

Loading Chart...

Areas of Expertise:

Prolyl Hydroxylase Inhibitors

ROR Modulators

Antibacterial Agents

Benzoimidazoles

Quinazolinones

Bicyclic Pyrazole Compounds

Triptolide Analogs

Sulfonamide Compounds

GlyT2 Modulators

KEAP1-Nrf2 Interaction

Aminoquinazolinyl Compounds

Thiazoles

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897900 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2024-02-13),

2. 11618744 - Benzoimidazoles as prolyl hydroxylase inhibitors (2023-04-04),

3. 11427601 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2022-08-30),

4. 10975068 - 6-aminopyridin-3-yl thiazoles as modulators of RORγT (2021-04-13),

5. 10975062 - 4-aminoquinazolinyl compounds as prolyl hydroxylase inhibitors (2021-04-13),

6. 10947252 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2021-03-16),

7. 10851083 - Benzoimidazoles as prolyl hydroxylase inhibitors (2020-12-01),

8. 10555941 - Alkyl linked quinolinyl modulators of RORγt (2020-02-11),

9. 10369146 - Phenyl linked quinolinyl modulators of RORγt (2019-08-06),

10. 10246442 - 4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors (2019-04-02),

11. 10201546 - Quinolinyl modulators of RORγt (2019-02-12),

12. 10150762 - Trifluoromethyl alcohols as modulators of RORγt (2018-12-11),

13. 9850236 - Trifluoromethyl alcohols as modulators of RORγt (2017-12-26),

14. 9845319 - Amide substituted thiazoles as modulators of RORyt (2017-12-19),

15. 9624225 - Quinolinyl modulators of RORγt (2017-04-18),

Title: Hariharan Venkatesan: Pioneering Innovator in the World of Technology

Introduction:

Hariharan Venkatesan is a visionary inventor based in San Diego, CA, whose passion for innovation and relentless pursuit of excellence have positioned him as a true pioneer in the realm of technology. With a remarkable portfolio of 42 patents, Venkatesan's contributions continue to inspire the next generation of inventors and technologists.

Latest Patents:

Venkatesan's latest patents showcase his cutting-edge work in the field of pharmaceuticals:

1. "Inhibitors of KEAP1-Nrf2 protein-protein interaction - Sultam compounds": These compounds are instrumental in treating disease states associated with the KEAP1-Nrf2 interaction, such as inflammatory bowel disease.

2. "Benzoimidazoles as prolyl hydroxylase inhibitors": These compounds have shown promise in the treatment of disease states modulated by prolyl hydroxylase activity.

Career Highlights:

Venkatesan has made significant contributions to organizations such as Janssen Pharmaceutica Nv and Emory University, where his expertise and innovative spirit have driven groundbreaking research and development in the pharmaceutical industry. His dedication to pushing the boundaries of what is possible has cemented his reputation as a trailblazer in technology.

Collaborations:

Throughout his career, Venkatesan has collaborated with esteemed colleagues such as David A Kummer and Rachel T Nishimura, fostering a culture of innovation and collaboration. These partnerships have yielded impactful results, further solidifying Venkatesan's standing as a thought leader in the industry.

Conclusion:

In conclusion, Hariharan Venkatesan's unwavering commitment to innovation and his remarkable track record of success make him a true icon in the world of technology. His pioneering work serves as a beacon of inspiration for aspiring inventors and underscores the transformative power of visionary thinking in shaping the future of technology.